Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Cholangiocarcinoma and Gallbladder Cancer Studies, and Nanoplatforms for cancer theranostics.
Machine learning-assisted prediction of organic solar cell efficiency from TCA triplelayer reflectance spectra
Cell-free DNA testing for early hepatocellular carcinoma surveillance
Impact of three-dimensional reconstruction visualization technology on short-term and long-term outcomes after hepatectomy in patients with hepatocellular carcinoma: a propensity‐score‐matched and inverse probability of treatment‐weighted multicenter study
Early warning of hepatocellular carcinoma in cirrhotic patients by three-phase CT-based deep learning radiomics model: a retrospective, multicentre, cohort study
First-in-human phase I/II safety and preliminary efficacy of PM1032, a bispecific antibody targeting CLDN18.2 and 4-1BB, in patients with advanced solid tumors.
Topologically protected subradiant cavity polaritons through linewidth narrowing enabled by dissipationless edge states
Strong radiative coupling between two quantum emitters with arbitrary mutual orientation via a silver nano-arc
High-Efficiency and High-Monochromaticity Semitransparent Organic Solar Cells Based on Optical Tamm States
Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures
Inverse design in quantum nanophotonics: combining local‐density‐of‐states and deep learning
The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis
Consensus on the tertiary prevention of primary liver cancer
Anatomic versus non-anatomic resection for early-stage intrahepatic cholangiocarcinoma: a propensity score matching and stabilized inverse probability of treatment weighting analysis
Additional file 4 of The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis
Additional file 3 of The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis
Additional file 2 of The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)
Unveiling atom‐photon quasi‐bound states in hybrid plasmonic‐photonic cavity
Single-photon blockade in quasichiral atom–photon interaction: simultaneous high purity and high efficiency
Cavity spectral-hole-burning to boost coherence in plasmon-emitter strong coupling systems
Inverse Design Local-Density-of-States via Deep Learning in Quantum Nanophotonics
Correction to: Consensus on the secondary prevention of primary liver cancer
Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease
Steering Room-Temperature Plexcitonic Strong Coupling: A Diexcitonic Perspective
The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients
Plasmonic-photonic cavity for high-efficiency single-photon blockade
Consensus on the secondary prevention of primary liver cancer
Update on overall survival (OS) of RESCUE: An open-label, phase 2 trial of camrelizumab (C) in combination with apatinib (A) in patients with advanced hepatocellular carcinoma (HCC).
Quantum exceptional chamber induced by large nondipole effect of a quantum dot coupled to a nano‐plasmonic resonator